A model of human whole blood lymphokine release for in vitro and ex vivo use
Open Access
- 11 January 2003
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 275 (1-2) , 69-79
- https://doi.org/10.1016/s0022-1759(03)00003-6
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Reduced Th1, but Not Th2, Cytokine Production by Lymphocytes after In Vivo Exposure of Healthy Subjects to EndotoxinInfection and Immunity, 2000
- Neue Entwicklungen in der Immundiagnostik intensivmedizinischer PatientenDeutsche Medizinische Wochenschrift (1946), 1999
- The clinical significance of T-cell superantigensTrends in Microbiology, 1998
- Cytokine production in whole blood cell cultures of patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 1997
- Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived fromMycoplasma arthritidis (MAS) and other mitogensRheumatology International, 1997
- In vivo effects of superantigensLife Sciences, 1995
- Impaired cytokine production in whole blood cell cultures of patients with urological carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritisCytokine, 1992
- Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole bloodBiochemical and Biophysical Research Communications, 1991
- Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 1988